Flushing Financial (NASDAQ: FFIC) Rule 144 notice lists 11,000 and 10,030-share rows

Rhea-AI Filing Summary

Flushing Financial Corporation submitted a Rule 144 notice relating to planned sales of Common Stock. The excerpt lists a sale row of 11,000 shares tied to an equity grant vesting dated 10/31/2020 and a sale row of 10,030 shares tied to an employer contribution dated 02/01/2023. Broker entries include Charles Schwab & Co., Inc. and Empower with dates in May 2026.

Key Figures

Rule 144 rows: 11,000 shares Rule 144 rows: 10,030 shares Broker entry: Charles Schwab & Co., Inc. +3 more

6 metrics

Rule 144 rows 11,000 shares equity grant vesting dated 10/31/2020

Rule 144 rows 10,030 shares employer contribution dated 02/01/2023

Broker entry Charles Schwab & Co., Inc. listed with date 05/08/2026 in table

Broker entry Empower listed with date 05/07/2026 in table

Table numeric value 176,550.00 numeric field shown on same row as 11,000 shares

Table numeric value 161,000.00 numeric field shown on same row as 10,030 shares

Key Terms

Rule 144, equity grant vesting, 401k payroll deferrals, Employer Contribution

4 terms

Rule 144 regulatory

"144: Securities To Be Sold"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

equity grant vesting financial

"equity grant vesting, 401k payroll deferrals"

401k payroll deferrals financial

"equity grant vesting, 401k payroll deferrals"

Employer Contribution financial

"Employer Contribution | Flushing Financil Corporation"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Charles Schwab & Co., Inc. Charles Schwab & Co., Inc. Lone Tree CO 80124	11000	176550.00	33883000	05/08/2026	NASDAQ
Common Stock	Empower 8515 E. Orchard Road Greenwood Village CO 80111	10030	161000.00	33883000	05/07/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	10/31/2020	equity grant vesting, 401k payroll deferrals	Flushing Financial Corporation			11000	10/31/2020	equity grant vesting, 401k payroll deferrals
Common Stock	02/01/2023	Employer Contribution	Flushing Financil Corporation			10030	02/01/2023	none

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the FFIC Rule 144 filing disclose?

The filing discloses planned sales of Common Stock under Rule 144. It includes rows showing 11,000 shares (equity grant vesting, 10/31/2020) and 10,030 shares (employer contribution, 02/01/2023). Broker entries are listed.

Which brokers are named in the FFIC excerpt?

The excerpt names Charles Schwab & Co., Inc. and Empower with address fragments and dates in May 2026 (05/07/2026 and 05/08/2026 respectively). These appear in the broker/contact fields of the table.

Are transaction proceeds or prices provided in the FFIC excerpt?

No explicit sale prices or proceeds uses are stated in the excerpt. The table lists numeric values but does not label a sale price or aggregate proceeds; the excerpt only shows share counts and associated dates.

Do the listed share rows represent total shares being sold?

The filing shows individual rows of 11,000 and 10,030 shares tied to specific grant or contribution dates. The excerpt does not state an aggregate total or confirm that these are the final amounts to be sold.